# 001177 · claims · run 40669292063

Model `claude-opus-5-5`, Claude Code 2.1.284, permission mode `default`. Tools: `Task`, `Bash`, `DesignSync`, `Edit`, `EnterWorktree`, `ExitWorktree`, `Glob`, `Grep`, `ListAgents`, `NotebookEdit`, `Read`, `ReportFindings`, `SendMessage`, `Skill`, `TaskCreate`, `TaskGet`, `TaskList`, `TaskStop`, `TaskUpdate`, `ToolSearch`, `WebFetch`, `WebSearch`, `Write`.

**Agent calls Bash**

```bash
cat docs/protocol.md; ls claims/001453/ paper/ claims/001177 2>&1; ls tools
```

Result: not kept, because it reads the paper's text.

**Agent calls Bash**

```bash
grep -n "^#" docs/protocol.md; ls claims/001453/ paper/ claims/001177 2>&1; ls tools
```

Result: not kept, because it reads the paper's text.

**Agent calls Read**

```json
{
 "file_path": "docs/protocol.md",
 "offset": 1,
 "limit": 182
}
```

```
1	# Protocol for an attempt
2	
3	Version: `pilot-12`. Record this version in the attempt's provenance.
4	
5	This is what agents, or people, do to attempt a target and deposit the
6	result. A target is a dataset in a public archive and a paper it names. How
7	each archive's datasets are named, versioned and read is in
8	[archives.md](archives.md); the examples here are from DANDI, the first. It is written from the pilot attempts
9	([pilot notes](pilot-notes.md)); the reasons for the rules are there.
10	
11	An attempt has three roles, each a separate run with a separate context:
12	
13	- The **reader** reads the paper and writes the claims file: every finding,
14	  and how each is to be tested, taken from the paper. A second reader checks
15	  it against the paper. Readers never see the dataset's data.
16	- The **author** tests the claims on the dataset. It reads the paper to
17	  understand the claims, but the claims file binds it: it cannot change a
18	  claim's statement, expected values or criterion. A method detail the file
19	  lacks it takes from the paper, citing the passage, and it asks a reader
20	  only when it believes the file misreads the paper.
[... 162 more lines not kept]
```

**Agent calls Read**

```json
{
 "file_path": "claims/001453/10.1016-j.cub.2025.04.027.yaml"
}
```

```
1	# Claims for Fouke, He, Loring & Naumann (2025) on dandiset 001453.
2	# Source: the accepted author manuscript in PubMed Central (PMC12218792), full text, read
3	# from its Results, figure legends and STAR Methods. The version of record is not open access.
4	#
5	# When these criteria were written, the author had seen the data check only: the file list,
6	# subject metadata, frame rates, units, trial structure and stimulus codes of every file, and
7	# the extent of positions. No claim's analysis had been run. The author had also read the
8	# outputs printed in the paper's own analysis notebook (Fig1-S1.ipynb, GitLab commit 33a5c29),
9	# which include per-stimulus median speeds and angular velocities and its statistics.
10	#
11	# The dandiset holds only the freely swimming tracking data of Figure 1 and Figure S1. Its
12	# stimulus codes 0 to 20 carry no names. The names come from the paper's code and from the
13	# stimulus software's protocol file (see stimulus-code-link), so the claims that need them
14	# use outside data and depend on that claim.
15	#
16	# Method choices fixed here, from the paper's Fig1-S1.ipynb where the Methods are silent: a
17	# trial is one stim_index; tracked frames only; positions smoothed with a Savitzky-Golay filter
18	# (21 frames, order 2); trials rejected when the absolute cumulative heading change exceeds
19	# 1000 degrees in the first 10 s or 2000 degrees in the first 35 s, or the mean speed exceeds
20	# 100 mm/s; measures taken from 3 s to 35 s after the first frame (the 3 s stationary phase is
[... 302 more lines not kept]
```

**Agent calls Bash**

```bash
wc -l paper/*.txt; head -30 paper/*.txt; grep -n -i "github\|zenodo\|code avail\|data avail\|supplementary" paper/*.txt | head -40
```

Result: not kept, because it reads the paper's text.

**Agent calls Bash**

```bash
cd paper; awk '{print NR": "length($0)}' *.txt | sort -t: -k2 -n -r | head -20; grep -n "^=\+\|^-\{10,\}\|SUPPLEMENT\|Supplementary" *.txt | head -30
```

```
<persisted-output>
Output too large (76.1KB). Full output saved to: /home/runner/.claude/projects/-home-runner-work-encore-encore/a5a0b50f-7a51-4376-bbc0-1790ee008538/tool-results/b3oriiwvc.txt

Preview (first 2KB):
7: 55868
23: 20075
409: 1000
407: 719
408: 694
392: 301
281: 293
297: 281
378: 278
244: 275
207: 270
357: 265
374: 263
293: 257
75: 255
353: 252
[... 8 more lines not kept]
```

**Agent calls Bash**

```bash
cd  && fold -s -w 200 paper/10.1093-brain-awaf312.txt > $TMPDIR/p.txt; wc -l $TMPDIR/p.txt; echo $TMPDIR
```

Result: not kept, because it reads the paper's text.

**Agent calls Read**

```json
{
 "file_path": "/tmp/claude-1001/p.txt",
 "limit": 400
}
```

```
File content (31465 tokens) exceeds maximum allowed tokens (25000). Use offset and limit parameters to read specific portions of the file, or search for specific content instead of reading the whole file.
```

**Agent calls Read**

```json
{
 "file_path": "/tmp/claude-1001/p.txt",
 "limit": 300
}
```

```
1	DOI: 10.1093/brain/awaf312
2	Version: as served by europe_pmc
3	Source: europe_pmc+crossref (paper-text-fetcher)
4	Stored: 2026-10-20
5	Extracted: as fetched; with 1 supplement file(s) from the PMC Open Access cloud data (PMC12597312), PDFs extracted with PyMuPDF (dehyphenated, NFKC), Word files with textutil
6	------------------------------------------------------------------------
7	719 brain Brain Brain Oxford University Press PMC12597312 12597312 12782157 40904197 10.1093/brain/awaf312 NIHMS2121151 Aberrant striatal firing mediates impulsive decision-making in a mouse model of 
8	Parkinson's disease Zhuang Xiaowen 1 2 3 4 Lemak Julia 5 6 7 8 Sridhar Sadhana 9 10 11 12 Nelson Alexandra B 13 14 15 16 ✉ 1 Kavli Institute for Fundamental Neuroscience, UCSF, San Francisco, CA 
9	94158, USA 2 Weill Institute for Neurosciences, UCSF, San Francisco, CA 94158, USA 3 Department of Neurology, UCSF, San Francisco, CA 94158, USA 4 Aligning Science Across Parkinson’s (ASAP) 
10	Collaborative Research Network, Chevy Chase, MD 20815, USA 5 Kavli Institute for Fundamental Neuroscience, UCSF, San Francisco, CA 94158, USA 6 Weill Institute for Neurosciences, UCSF, San Francisco, 
11	CA 94158, USA 7 Department of Neurology, UCSF, San Francisco, CA 94158, USA 8 Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA 9 Kavli Institute 
12	for Fundamental Neuroscience, UCSF, San Francisco, CA 94158, USA 10 Weill Institute for Neurosciences, UCSF, San Francisco, CA 94158, USA 11 Department of Neurology, UCSF, San Francisco, CA 94158, 
13	USA 12 Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA 13 Kavli Institute for Fundamental Neuroscience, UCSF, San Francisco, CA 94158, USA 14 
14	Weill Institute for Neurosciences, UCSF, San Francisco, CA 94158, USA 15 Department of Neurology, UCSF, San Francisco, CA 94158, USA 16 Aligning Science Across Parkinson’s (ASAP) Collaborative 
15	Research Ne
[... 285 more lines not kept]
```

**Agent calls Read**

```json
{
 "file_path": "/tmp/claude-1001/p.txt",
 "offset": 300,
 "limit": 280
}
```

```
300	Kavli Institute for Fundamental Neuroscience, UCSF, San Francisco, CA 94158, USA; 
301	Weill Institute for Neurosciences, UCSF, San Francisco, CA 94158, USA; 
302	Department of Neurology, UCSF, San Francisco, CA 94158, USA; 
303	Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA. Alexandra B Nelson, 
304	Kavli Institute for Fundamental Neuroscience, UCSF, San Francisco, CA 94158, USA; 
305	Weill Institute for Neurosciences, UCSF, San Francisco, CA 94158, USA; 
306	Department of Neurology, UCSF, San Francisco, CA 94158, USA; 
307	Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA. Data availability Data and original code have been deposited at Zenodo and are publicly 
308	available as of the date of publication ( https://doi.org/10.5281/zenodo.15258978 ). Raw in vivo electrophysiology datasets have been deposited in DANDI ( https://dandiarchive.org/dandiset/001177 ) 
309	and are publicly available as of publication. Detailed protocols and analysis code are listed within the ‘Materials and methods’ section. Funding This work was supported by grants from the 
310	Parkinson’s Foundation (PF-PRF-836910 and PF-LAUNCH-1248418 to X.Z.), the National Institute of Neurological Disorders and Stroke (NINDS) (R01NS101354 to A.B.N.), Aligning Science Across Parkinson's 
311	(ASAP-020529 to A.B.N.) through the Michael J. Fox Foundation for Parkinson's Research (MJFF), and by the Richard and Shirley Cahill Endowed Chair in Parkinson's Disease Research (to A.B.N.). For 
312	open access, the authors have applied a CC BY 4.0 public copyright license to all Author Accepted Manuscripts arising from this submission. Competing interests The authors report no competing 
313	interests. Supplementary material Supplementary material is available at Brain online. References 1. El Massioui  N, Lamirault  C, Yague  S, et al.   Impaired decision making and loss of 
314	inhibitory-control in a
[... 265 more lines not kept]
```

**Agent**

Now the supplement.

**Agent calls Bash**

```bash
grep -n "SUPPLEMENT\|^=====\|awaf312_Supplementary\|Supplementary Methods\|Supplementary Table 1\|Table S1" $TMPDIR/p.txt | head -30
```

```
76:excluded from analysis. Details are provided in the Supplementary material . Statistical analysis The experimental design and statistical analysis of all key experiments are summarized in Table S1 of 
78:previous studies. We aimed to achieve >80% power to detect a significant difference with a two-sided α of 0.05, using the statistical tests reported in Table S1 . All data are presented as the mean ± 
85:Supplementary Table 1 ). There were fewer dopaminergic cell bodies in the substantia nigra pars compacta (SNc) in 6-OHDA-treated versus control mice ( Supplementary Fig. 1C and D ). 6-OHDA-treated 
290:dopamine replacement therapy with a goal of preventing or ameliorating ICD. Supplementary Material awaf312_Supplementary_Data Acknowledgements The authors wish to thank Drs Elyssa Margolis, Joshua 
407:neurons. J Neurosci. 1996;16:6579–6591. Associated Data Supplementary Materials awaf312_Supplementary_Data Data Availability Statement Data and original code have been deposited at Zenodo and are
```

**Agent calls Bash**

```bash
grep -n -i "supplement\|^\[\|^#\|^---" $TMPDIR/p.txt | sed -n '1,200p' | awk -F: '$1>580' | head -40
```

```
875:[1] Impaired decision making and loss of inhibitory-control in a rat model of Huntington disease. Front Behav Neurosci. 2016. 10.3389/fnbeh.2016.00204
877:[2] Behavioral models of impulsivity in relation to ADHD: Translation between clinical and preclinical studies. Clin Psychol Rev. 2006. 10.1016/j.cpr.2006.01.001
879:[3] Parkinson’s disease: Clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008. 10.1136/jnnp.2007.131045
881:[4] Impulse control disorders in Parkinson’s disease: From bench to bedside. Front Neurosci. 2021. 10.3389/fnins.2021.654238
883:[5] Impulse control disorders in Parkinson’s disease. Am J Psychiatry. 2019. 10.1176/appi.ajp.2018.18040465
885:[6] Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl). 2010. 10.1007/s00213-009-1697-y
887:[7] Impulse control disorders in Parkinson’s disease: Clinical characteristics and implications. Neuropsychiatry (London). 2011. 10.2217/npy.11.11
889:[8] Pramipexole-induced impulsivity in mildparkinsonian rats: A model of impulse control disorders in Parkinson’s disease. Neurobiol Aging. 2019. 10.1016/j.neurobiolaging.2018.11.021
891:[9] Dopamine and reward hypersensitivity in Parkinson’s disease with impulse control disorder. Brain. 2020. 10.1093/brain/awaa198
893:[10] Delay discounting in Parkinson’s disease: A systematic review and meta-analysis. Behav Brain Res. 2023. 10.1016/j.bbr.2022.114101
895:[11] Intact reward learning but elevated delay discounting in Parkinson’s disease patients with impulsive-compulsive spectrum behaviors. Neuropsychopharmacology. 2010. 10.1038/npp.2010.84
897:[12] Impulse control disorders in Parkinson’s disease versus in healthy controls: A different predictive model. J Neuropsychol. 2020. 10.1111/jnp.12193
899:[13] Heterogeneous coding of temporally discounted values in the dorsal and ventral striatum during intertemporal choice. Neuron. 2011. 10.1016/j.neuron.2010.11.041
901:[14] Dopaminergic function and
[... 26 more lines not kept]
```

**Agent calls Bash**

```bash
grep -n -i "supplement\|=====\|SUPP" $TMPDIR/p.txt | awk -F: '$1>1000' | head -40
```

```
1085:##### Supplement: awaf312_supplementary_data.pdf
1090:Supplementary material 
1129:The Supplementary material includes: 
1654:Additional details are provided in the Supplementary material. Briefly, slice electrophysiology was
```

**Agent calls Read**

```json
{
 "file_path": "/tmp/claude-1001/p.txt",
 "offset": 1085,
 "limit": 700
}
```

```
1085	##### Supplement: awaf312_supplementary_data.pdf
1086	
1087	=== page 1 ===
1088	 
1089	- 1 - 
1090	Supplementary material 
1091	 
1092	Aberrant Striatal Firing Mediates Impulsive  
1093	Decision-Making in a Mouse Model of Parkinson's Disease 
1094	 
1095	Xiaowen Zhuang,1,2,3,4 Julia Lemak,1,2,3,4 Sadhana Sridhar1,2,3,4 and Alexandra B. Nelson1,2,3,4 
1096	 
1097	Author affiliations: 
1098	1 Kavli Institute for Fundamental Neuroscience, UCSF, San Francisco, CA 94158, USA 
1099	2 Weill Institute for Neurosciences, UCSF, San Francisco, CA 94158, USA 
1100	3 Department of Neurology, UCSF, San Francisco, CA 94158, USA 
1101	4 Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, 
1102	MD, 20815, USA 
1103	 
1104	Correspondence to: Alexandra B. Nelson 
[... 680 more lines not kept]
```

**Agent calls Read**

```json
{
 "file_path": "/tmp/claude-1001/p.txt",
 "offset": 1784,
 "limit": 700
}
```

```
1784	using 
1785	custom 
1786	analysis 
1787	code 
1788	written 
1789	in 
1790	Python 
1791	(https://zenodo.org/doi/10.5281/zenodo.10703139). This code extracted specific task-related 
1792	events, including trial start, cue light start, left and right nosepokes, reward consumptions and 
1793	
1794	=== page 19 ===
1795	 
1796	- 19 - 
1797	timeouts during both forced and free choice trials. Choice performance in each block of the delay 
1798	discounting task was measured as the percentage of free choice trials (excluding omissions) on 
1799	which mice chose the delayed/large reward. Each mouse was trained on the delay discounting task 
1800	until it reached stable baseline performance. Stable baseline was first assessed in each mouse by 
1801	visually inspecting discounting curves for three sessions, then by calculation of the coefficient of 
1802	variation for choice of the delayed/large outcome (stable defined as CV < 20% in at least 3 blocks 
1803	for three consecutive sessions, or CV < 20% in each block for two consecutive sessions). Once 
[... 680 more lines not kept]
```

**Agent calls Bash**

```bash
grep -n "Fig. *4\|Fig. *6\|Fig. *S5\|Fig. *S8\|Fig.4\|Fig.6\|FigS5\|Fig.S5\|Fig.S8\|Fig. *5\|Fig.5\|Fig. *S7\|Fig. *2\|Fig.2\|Fig. *3\|Fig.3\|=== page" $TMPDIR/p.txt | awk -F: '$1>2483'
```

```
2589:=== page 28 ===
2661:Fig. 2D 
2692:Fig. 2E 
2719:Fig. 2F 
2729:=== page 29 ===
2735:Fig. 2G 
2747:Fig. 2H 
2907:=== page 30 ===
3053:=== page 31 ===
3106:Fig. 3A, 
3117:Fig. 3A, 
3128:Fig. 3A, 
3139:Fig. 3B, 
3150:Fig. 3B, 
3161:Fig. 3B, 
3238:Fig. 4B 
3251:=== page 32 ===
3256:Fig. 4C 
3271:Fig. 4D 
3280:Fig. 4E 
[... 25 more lines not kept]
```

**Agent**

Full text, Methods and supplement (with Table 1) are all present. Reading the remaining statistics table rows now.

**Agent calls Bash**

```bash
sed -n '2484,3712p' $TMPDIR/p.txt | tr -s ' \n' ' ' | sed 's/=== page/\n=== page/g'
```

```
3s: p = 0.004 6s: p >0.99 9s: p > 0.99 PPX effects on latency to trigger (Park/PPX) Fig.S2H Within animal 2way ANOVA, Bonferroni N = 31 NA Reward size: F(1, 117) = 0.1514, p = 0.6979 delay: F(3, 120) = 3.021, p = 0.0325 delay x size: F(3, 117) = 1.440, p = 0.2347 0s: p > 0.99 3s: p = 0.89 6s: p > 0.99 9s: p = 0.63 PPX effects on latency to trigger immediate/small rewards (Park) Fig. S2G, H Within animal 2way ANOVA, Bonferroni N = 31 NA delay: F(3, 118) = 0.667, p = 0.574 PPX: F(1, 114) = 4.505, p = 0.020 delay x PPX: F(3, 114) = 1.737, p = 0.163 0s: p = 0.05 3s: p = 0.02 6s: p = 0.98 9s: p = 0.90 A value during PPX off (Park) Fig. S2I Within animal one-way ANOVA, Bonferroni N = 31 NA Park vs. PPX: p < 0.0001 PPX vs. PPX off: p < 0.0001 K value during PPX off (Park) Fig. S2J Within animal one-way ANOVA, Bonferroni N = 31 NA Park vs. PPX: p = 0.03 PPX vs. PPX off: p > 0.99 AUC value during PPX off (Park) Fig. S2K Within animal one-way ANOVA, Bonferroni N = 31 NA Park vs. PPX: p < 0.0001 PPX vs. PPX off: p = 0.0019 
=== page 28 === - 28 - A77636 effects on velocity Fig. 2B&C Within animal WSR Ctrl: N = 10 Park: N = 16 NA Ctrl: Pre vs. A77636 p = 0.16 Park: Pre vs. A77636 p = 0.02 DD curve during baseline (Ctrl vs. Park) Fig. 2D&E Between group 2way ANOVA, Bonferroni Ctrl: N = 10 Park: N = 16 NA Depletion: F(1, 96) = 2.26, p = 0.1360, ηp2 = 0.0159 Delay: F(3, 96) = 13.59, p < 0.0001, ηp2 = 0.2868 delays x Depletion: F(3, 96) = 0.07, p = 0.9781, ηp2 = 0.0014 0s: p > 0.99 3s: p > 0.99 6s: p > 0.99 9s: p > 0.99 A77636 effects on DD curve (Ctrl) Fig. 2D Within animal 2way ANOVA, Bonferroni N = 10 NA A77636: F(1, 36) = 1.05, p = 0.3115, ηp2 = 0.0134 delay: F(3, 36) = 5.50, p = 0.0032, ηp2 = 0.2988 delays x A77636: F(3, 36) = 0.75, p = 0.5315, ηp2 = 0.0028 0s: p > 0.99 3s: p = 0.81 6s: p > 0.99 9s: p > 0.99 A77636 effects on DD curve (Park) Fig. 2E Within animal 2way ANOVA, Bonferroni N = 16 NA A77636: F(1, 60) = 45.68, p < 0.0001, ηp2 = 0.0495 delay: F(3, 60) = 12.93, p < 0.
[... 6 more lines not kept]
```

**Agent calls Bash**

```bash
grep -rl "001177" --include=*.yaml --include=*.json --include=*.md . 2>/dev/null | grep -v transcripts | head; ls
```

```
./papers/manifest.yaml
./targets/dandisets.json
LICENSE
README.md
attempts
bunfig.toml
claims
docs
encore_science
entries
node_modules
package-lock.json
package.json
paper
papers
pnpm-lock.yaml
pyproject.toml
questions
queue
schemas
[... 6 more lines not kept]
```

**Agent calls Bash**

```bash
python3 -c "
import json;d=json.load(open('targets/dandisets.json'))
it=d if isinstance(d,list) else d.get('dandisets',d)
for x in (it if isinstance(it,list) else it.values()):
  if '001177' in json.dumps(x): print(json.dumps(x,indent=1)[:3000])
"; grep -n -B2 -A10 "001177" papers/manifest.yaml | head -30; ls schemas
```

```
[
 {
  "dandiset": "000003",
  "name": "Physiological Properties and Behavioral Correlates of Hippocampal Granule Cells and Mossy Cells",
  "published_version": "0.260218.2052",
  "asset_count": 101,
  "size_gb": 2559.25,
  "data_standards": [
   "Neurodata Without Borders (NWB)"
  ],
  "species": [
   "House mouse"
  ],
  "approaches": [
   "electrophysiological approach",
   "behavioral approach"
  ],
  "papers": [
   {
    "doi": "10.1016/j.neuron.2016.12.011",
[... 115 more lines not kept]
```

**Agent calls Bash**

```bash
python3 -c "
import json;d=json.load(open('targets/dandisets.json'))
for x in d:
  if x['dandiset']=='001177': print(json.dumps(x,indent=1))
"; curl -s -m 20 https://api.dandiarchive.org/api/dandisets/001177/ | head -c 1500; echo; curl -s -m 20 https://zenodo.org/api/records/15258978 | python3 -c "import json,sys;d=json.load(sys.stdin);print(d['metadata']['title']);print(d['metadata'].get('description','')[:1500]);[print(f['key'],f['size'],f['links']['self']) for f in d['files']]"
```

Result: the fetched text is not kept.

**Agent calls Bash**

```bash
curl -s -m 20 https://api.dandiarchive.org/api/dandisets/001177/versions/0.250902.2127/ | python3 -c "import json,sys;d=json.load(sys.stdin);print(d['name']);print(d.get('description'));print(d.get('assetsSummary'))"; for r in 10703139 10703131; do curl -sL -m 20 https://zenodo.org/api/records/$r | python3 -c "import json,sys;d=json.load(sys.stdin);print(d['id'],d['metadata']['title'],d['metadata'].get('version'));print(d['metadata'].get('description','')[:800]);[print(f['key'],f['size'],f['links']['self']) for f in d['files']]; print([x for x in d['metadata'].get('related_identifiers',[])])"; done
```

Result: the fetched text is not kept.

**Agent calls Bash**

```bash
mkdir -p $TMPDIR/code && cd $TMPDIR/code && curl -sL -m 60 -o a.zip "https://zenodo.org/api/records/10703140/files/UCSF-Nelson-Lab/ICD-Cognitive-Analysis-ICD.zip/content" && curl -sL -m 60 -o b.zip "https://zenodo.org/api/records/10703132/files/UCSF-Nelson-Lab/ICD-Cognitive-Arduino-ICD.zip/content" && unzip -o -q a.zip && unzip -o -q b.zip && find . -type f | grep -v zip$; curl -sL -m 20 "https://zenodo.org/api/records/15258978/files/README_ICD_CognitiveAssessment.txt/content"
```

Result: the fetched text is not kept.

**Agent calls Bash**

```bash
cd $TMPDIR/code/UCSF-Nelson-Lab-ICD-Cognitive-Analysis-5528e22 && cat README.md && wc -l * && cat delay_discounting_task.py Summary_Cognitive.m
```

````
<persisted-output>
Output too large (71.9KB). Full output saved to: /home/runner/.claude/projects/-home-runner-work-encore-encore/a5a0b50f-7a51-4376-bbc0-1790ee008538/tool-results/bao2ohtkp.txt

Preview (first 2KB):
"# ICD-Cognitive-Analysis"

## How to use the Python Analysis

1. Open the python file using command line tool (Terminal for MacOS), for example
```python
python python2.py
```

2. Open the data file (select `open` in the option) using via the opened window.

3. Select OK in the pop-up window

4. Results are shown in the terminal.

## PIP requirement
[... 44 more lines not kept]
````

**Agent calls Bash**

```bash
cd $TMPDIR/code/UCSF-Nelson-Lab-ICD-Cognitive-Analysis-5528e22 && cat Summary_Cognitive.m; grep -n "def \|percent\|omission\|large\|small\|block" delay_discounting_task.py | head -120
```

```
%%
clear all;
close all;
% Specify the Excel file path
filePath = '{Your file path}';
% Get the sheet names in the Excel file
[~, sheetNames] = xlsfinfo(excelFilePath);
% Initialize cell arrays to store averages and standard errors for each sheet
averages = cell(numel(sheetNames), 1);
stdErrors = cell(numel(sheetNames), 1);
% Define the column index for "Animal ID" (assuming it's in the first column)
animalIDColumn = 1;

%% calculate the averages across different days of PPX injection
% Initialize cell arrays to store averages and standard errors for each sheet
SeparateAvg = cell(numel(sheetNames), 1);
SeparateSTE = cell(numel(sheetNames), 1);

% Define the column index for "Animal ID" (assuming it's in the first column)
animalIDColumn = 1;
[... 457 more lines not kept]
```

**Agent calls Bash**

```bash
cd $TMPDIR/code/UCSF-Nelson-Lab-ICD-Cognitive-Analysis-5528e22 && sed -n 397,453p delay_discounting_task.py; grep -n "large_r\b\|large_r\"\]\|/ *(\|percent\|ratio\|free\|forced" delay_discounting_task.py | sed -n 1,80p
```

```
def calculate_ms(self, x, y): # x is larger than y
        xhour = int(x.split(":")[0])
        xmin = int(x.split(":")[1])
        xsec = int(x.split(":")[2])
        xms = int(x.split(":")[3])

        yhour = int(y.split(":")[0])
        ymin = int(y.split(":")[1])
        ysec = int(y.split(":")[2])
        yms = int(y.split(":")[3])

        if xms > yms:
            diff = xms - yms
            if xsec > ysec and xmin > ymin:
                diff = diff + (xsec - ysec)*1000 + (xmin - ymin)*60*1000
            else:
                diff_sec = ((xmin - ymin)*60 + xsec) - ysec
                diff = diff + diff_sec*1000
        else:
            diff = 0
[... 55 more lines not kept]
```

**Agent calls Bash**

```bash
cat schemas/claims.schema.json | head -250; sed -n 1,80p tools/claims_check.py
```

```
{
  "$schema": "https://json-schema.org/draft/2020-12/schema",
  "title": "Claims proposed for one target (a dataset and one of its papers)",
  "description": "Draft. To be revised after the pilot.",
  "type": "object",
  "additionalProperties": false,
  "required": [
    "schema_version",
    "dataset",
    "paper",
    "claims"
  ],
  "properties": {
    "schema_version": {
      "const": 2
    },
    "dataset": {
      "description": "The dataset the claims are tested on: the archive and the dataset's identifier there.",
      "type": "object",
      "additionalProperties": false,
[... 310 more lines not kept]
```

**Agent calls Bash**

```bash
sed -n 250,330p schemas/claims.schema.json; ls claims | head -50; grep -l "elsewhere" claims/*/*.yaml | head
```

```
"value"
      ],
      "properties": {
        "quantity": {
          "type": "string"
        },
        "value": {
          "type": "number"
        },
        "tolerance": {
          "type": "number",
          "minimum": 0
        },
        "unit": {
          "type": "string"
        }
      }
    },
    "statistic": {
      "type": "object",
[... 121 more lines not kept]
```

**Agent calls Bash**

```bash
grep -n -B3 -A3 "elsewhere" claims/000166/*.yaml | head -40
```

```
404-  criterion: The comparison uses monkey data reproduced from Bollimunta et al. (2008) and the paper gives
405-    no measure of similarity. The mouse side can be shown (laminar 3-6 Hz traces, CSD profile, Figure 3E);
406-    the claim itself is recorded as methods_underspecified.
407:  data: elsewhere
408-  where: Bollimunta et al. 2008, J. Neurosci. 28, 9976-9988, doi:10.1523/JNEUROSCI.2699-08.2008 (published
409-    figure, no deposit)
410-- id: fig4a-unit-counts
```

**Agent calls Bash**

```bash
cd $TMPDIR && python3 -c "
import fitz
d=fitz.open('paper/10.1093-brain-awaf312.supp.pdf')
for p in (6,9):
  d[p].get_pixmap(dpi=110).save(f'$TMPDIR/s{p+1}.png')
print(len(d))
"
```

Result: not kept, because it reads the paper's text.

**Agent calls Bash**

```bash
cd $TMPDIR && which pdftoppm && pdftoppm -f 7 -l 7 -r 100 -png paper/10.1093-brain-awaf312.supp.pdf s7 && pdftoppm -f 10 -l 10 -r 100 -png paper/10.1093-brain-awaf312.supp.pdf s10; ls *.png
```

Result: not kept, because it reads the paper's text.

**Agent calls Bash**

```bash
(uv run --help >/dev/null 2>&1 && echo uv); python3 -c "import pypdfium2" 2>&1; pip download --help >/dev/null 2>&1 && echo pip; ls .venv 2>/dev/null | head
```

```
uv
Traceback (most recent call last):
  File "<string>", line 1, in <module>
    import pypdfium2
ModuleNotFoundError: No module named 'pypdfium2'
pip
```

**Agent calls Bash**

```bash
cd $TMPDIR && uv run --no-project --with pymupdf python -c "
import fitz
d=fitz.open('paper/10.1093-brain-awaf312.supp.pdf')
for p in (6,9):
  d[p].get_pixmap(dpi=110).save(f's{p+1}.png')
" 2>&1 | tail -2; ls *.png
```

Result: not kept, because it reads the paper's text.

**Agent calls Read**

```json
{
 "file_path": "/tmp/claude-1001/s7.png"
}
```

Result: no output.

**Agent calls Read**

```json
{
 "file_path": "/tmp/claude-1001/s10.png"
}
```

Result: no output.

**Agent calls Bash**

```bash
cd $TMPDIR/code/UCSF-Nelson-Lab-ICD-Cognitive-Analysis-5528e22 && sed -n 780,860p delay_discounting_task.py; sed -n 570,600p delay_discounting_task.py
```

```
print("\nOverall latency B and D avg time",(int(result["B15"]["total_latency_centri_Bin"]) + int(result["B15"]["total_latency_centri_Din"]))//int(result["B15"]["none_omission"]))
            except:
                print("\nNo none_omission")

        except:
            print("no b15")


        small_r_total = result["B3"]["small_r"] + result["B6"]["small_r"] + result["B9"]["small_r"]
        large_r_total = result["B3"]["large_r"] + result["B6"]["large_r"] + result["B9"]["large_r"]

        try:
            with open('fileB3.csv', 'w') as f:
                for key in result["B3"].keys():
                    f.write("%s,%s\n"%(key,result["B3"][key]))
            with open('fileB6.csv', 'w') as f:
                for key in result["B6"].keys():
                    f.write("%s,%s\n"%(key,result["B6"][key]))
            with open('fileB9.csv', 'w') as f:
                for key in result["B9"].keys():
[... 93 more lines not kept]
```

**Agent calls Bash**

```bash
cd $TMPDIR/code && cat UCSF-Nelson-Lab-ICD-Cognitive-Arduino-f7cff8b/README.md | head -30; grep -n "delay\|50000\|15\b\|reward" UCSF-Nelson-Lab-ICD-Cognitive-Arduino-f7cff8b/DelayDiscountingTask/DelayDiscountingTask.ino | head -30
```

```
This repository contains Arduino code designed to control operant conditioning boxes, which are used in behavioral experiments. The code includes both behavioral shaping phases and the Delay Discounting (DD) phase. 
42:char msg15[] = "cen tri";
55:char msg29[] = "s reward delivery";
57:char msg31[] = "l reward delivery";
187:void forced_left(unsigned long trial_n, unsigned long delay_t) {
278:    logData(msg15);
300:      delay (100);
402:delay(1);
409:void forced_right(unsigned long trial_n, unsigned long delay_t) {
410:Serial.println(delay_t);
505:    logData(msg15);
526:      Serial.println(delay_t);
531:if (current_state == 4 && millis() - timer_4 > delay_t) {//delay time discounting
535:      delay (100);
537:      delay (250);
539:      delay (100);
541:      delay (250);
543:      delay (100);
651:delay(1);
659:void free_choice (unsigned long trial_n, unsigned long delay_t) {
[... 12 more lines not kept]
```

**Agent calls Write**

```json
{
 "file_path": "claims/001177/10.1093-brain-awaf312.yaml",
 "content": "# Claims for Zhuang, Lemak, Sridhar & Nelson (2025), Brain 149:238-251, on dandiset 001177.\n# Written by an agent (model \"claude-opus-5-5\", Claude Code, runner \"GitHub Actions\"), 2026-10-28,\n# protocol pilot-12 as stated in docs/protocol.md. The writer did not look at the dandiset's data or\n# files; only its title and description on the archive were read.\n#\n# Text read: the version of record (open access, CC BY), full text as served by Europe PMC\n# (PMC12597312), with its one supplement, awaf312_supplementary_data.pdf (Figures S1 to S8 and\n# legends, Supplementary Materials and methods, and Table 1, \"Experimental analysis and\n# statistics\"). Figure panels of the main paper were not available as images; values in the main\n# figure legends were read from the text. The pie-chart percentages of Figures S5D and S8A-B were\n# read from the supplement PDF (pages 7 and 10), as the text holds only the legends.\n#\n# Code read. The paper links (1) UCSF-Nelson-Lab/ICD-Cognitive-Analysis, tag ICD, commit 5528e22\n# (Zenodo doi:10.5281/zenodo.10703139, record 10703140): Python scripts that count task events per\n# block of the delay discounting task (delay_discounting_task.py, phase2.py, phase3.py) and\n# Summary_Cognitive.m, which averages each mouse's sessions within a condition, fits\n# V = A/(1 + K*D) to the four delays with lsqcurvefit (start A = 1, K = 0.5, no bounds) and takes\n# the AUC as the trapezoidal integral of the fitted values at D = 0, 3, 6, 9 s; (2)\n# UCSF-Nelson-Lab/ICD-Cognitive-Arduino, tag ICD, commit f7cff8b (Zenodo doi:10.5281/zenodo.10703131),\n# the operant box control code. No code is linked for the electrophysiology: the Methods say firing\n# was analysed in NeuroExplorer 4.133 and statistics run in GraphPad Prism 10.\n#\n# Data the paper used. Mice (C57BL/6 background, male and female, 3 to 7 months) received\n# bilateral dorsolateral striatum injections of 6-OHDA (parkinsonian, Park) or saline (control,\n# Ctrl). Drugs: pramipexole (PPX, 0.5 mg/kg i.p., tested about 4 h after injection), A77636\n# (1 mg/kg i.p., tested 30 min after), CNO (3 mg/kg for hM4Di, 1 mg/kg for hM3Dq).\n# - In vivo electrophysiology (Figure 4, Figure 6F-K, Figures S5 and S8): D1-Cre and A2a-Cre mice\n#   with ChR2-eYFP in the left dorsomedial striatum (DMS) and DMS optrode arrays; Blackrock\n#   CerePlex Direct, 30 kHz, 154-8800 Hz; manual sorting in Plexon Offline Sorter; units classed as\n#   putative MSNs by waveform (peak to valley, peak width) and ISI distribution; optically\n#   identified dMSNs (D1-Cre) and iMSNs (A2a-Cre) from responses to blue light at the end of each\n#   session. Sessions of 330 min, PPX (or saline) injected after a 30 min baseline; recordings in\n#   the open field. Ctrl N = 7 and Park N = 11 mice for putative MSNs (117 and 214 units);\n#   labelled dMSNs Ctrl 3 mice / 12 cells, Park 5 / 24; iMSNs Ctrl 4 / 10, Park 4 / 16; saline\n#   sessions 4 mice / 40 units; four PPX sessions per mouse for Figure 6. The dandiset holds these\n#   recordings: the paper says \"Raw in vivo electrophysiology datasets have been deposited in\n#   DANDI\", and the archive's description (18 subjects, Units, ElectricalSeries, LFP) matches.\n#   Its description also mentions light pulses of 100 ms at 1 Hz, 4000 pulses, 0.5 to 4 mW.\n# - Behaviour, histology, rotarod, locomotion and slice physiology: deposited by the paper at\n#   Zenodo doi:10.5281/zenodo.15258978 (files Data_ICD_Fig1&2&5&6_CognitiveAssay.zip,\n#   Data_ICD_Fig1_Rotarod_PPX.xlsx, Data_ICD_Fig3_HistologyQuantification_striatum_raw.xlsx,\n#   Data_ICD_FigS1_SNcTH_CellCounting_RawImages.xlsx, Data_ICD_A77636OpenField_Raw.zip,\n#   Data_ICD_Fig5_DREADDLocomotion_Raw.zip, Data_ICD_FigS6_SliceValidation.xlsx and raw images).\n#   Claims on them have data elsewhere. Delay discounting cohorts: PPX Ctrl 16 and Park 31 mice;\n#   A77636 Ctrl 10 and Park 16; DREADD mCherry 15, hM4Di 12, hM3Dq 12. Each session has four blocks\n#   (delays 0, 3, 6, 9 s) of 5 forced delayed/large, 5 forced immediate/small and 20 free choice\n#   trials; the measure is the percentage of free choice trials, omissions excluded, on which the\n#   delayed/large reward was chosen.\n#\n# Method shared by the electrophysiology claims, from the Supplementary Materials and methods\n# (\"In vivo electrophysiology\" and \"Experimental design & statistical analysis, In vivo\n# electrophysiology\"): firing rates in 1 min bins; baseline -30 to 0 min; the post-drug epoch\n# 240 to 300 min, split into 241-270 and 271-300 min; a unit is 'increase' type when a Wilcoxon\n# signed-rank test (p < 0.01) finds a significant increase against baseline in both 30 min post\n# epochs, 'decrease' when a significant decrease in both, 'no change' when neither (a unit\n# significant in one epoch only is not defined by the paper; it is counted as no change, and the\n# count of such units reported); optical identification by a PSTH around laser onset, the rate\n# exceeding the 99% confidence interval of baseline within 15 ms of onset and staying above it for\n# at least 15 ms, with light-evoked waveforms not distinguishable from spontaneous ones.\n# Details these sources leave open, with the readings allowed, used by several claims:\n# - Putative MSN classification: the thresholds are not given; readings are (a) a classification\n#   deposited with the units by the authors, (b) the criteria of the cited papers (Berke et al.\n#   2004, Neuron 43:883; Gage et al. 2010, Neuron 67:466) applied to peak to valley and peak width.\n# - Optical identification: the PSTH bin width, the baseline window for the 99% interval and the\n#   waveform test are not given; readings are (a) a label deposited by the authors, (b) 1 ms bins,\n#   the pre-pulse interval of each pulse as baseline, and waveform correlation as the comparison.\n# - The pairing in the signed-rank test for response type: readings are (a) the 30 baseline 1 min\n#   bins paired in time order with the 30 bins of each post epoch, (b) the same two sets of 30\n#   bins compared by an unpaired rank-sum test.\n# - Which PPX session Figure 4 and Figure S5 use: readings are (a) the first PPX session of each\n#   mouse, (b) every PPX session pooled, each unit-session counted once.\nschema_version: 2\ndataset:\n  archive: dandi\n  id: \"001177\"\npaper: doi:10.1093/brain/awaf312\nclaims:\n- id: fig1b-th-loss\n  statement: 6-OHDA caused about 50% loss of TH immunofluorescence in the rostral dorsolateral and\n    dorsomedial striatum, with less depletion in the ventral striatum.\n  source: Results, Dopamine D2/3R agonist pramipexole causes impulsive decision-making in parkinsonian\n    mice, paragraph 1; Figure 1B\n  quote: we found approximately 50% loss of TH signal in the rostral dorsolateral and dorsomedial\n    striatum (DMS), with less marked depletion in the ventral striatum (VS\n  statistics:\n  - about: DMS against DLS\n    test: Kruskal-Wallis, Dunn's\n    p: 0.09\n    n: 44\n  - about: VS against DMS\n    test: Kruskal-Wallis, Dunn's\n    p: 0.0003\n    n: 44\n  - about: VS against DLS\n    test: Kruskal-Wallis, Dunn's\n    p: 0.0001\n    p_relation: \"<\"\n    n: 44\n  expected:\n  - quantity: loss of TH signal in DLS and DMS, relative to control\n    value: 50\n    tolerance: 5\n    unit: percent\n  criterion: As in the Supplementary methods (Histology, quantification and microscopy), corrected\n    total fluorescence per subregion normalized to control sections, and a Kruskal-Wallis test with\n    Dunn's comparisons between subregions (Table 1). Reproduced when the losses in DLS and DMS are\n    within tolerance of 50%, DLS and DMS do not differ at p < 0.05, and VS is less depleted than\n    both at p < 0.05.\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig3_HistologyQuantification_striatum_raw.xlsx\n    and the striatal TH raw images)\n- id: figs1d-snc-cells\n  statement: Parkinsonian mice had fewer TH-positive dopamine neurons in the substantia nigra pars\n    compacta than controls.\n  source: Results, Dopamine D2/3R agonist pramipexole causes impulsive decision-making in parkinsonian\n    mice, paragraph 1; Figure S1D\n  quote: There were fewer dopaminergic cell bodies in the substantia nigra pars compacta (SNc) in\n    6-OHDA-treated versus control mice\n  statistics:\n  - test: Mann-Whitney U\n    p: 0.001\n    p_relation: \"<\"\n    n: 9 control and 21 parkinsonian mice\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_FigS1_SNcTH_CellCounting_RawImages.xlsx)\n- id: fig1c-rotarod\n  statement: Parkinsonian mice fell sooner from the accelerating rotarod than controls, and PPX\n    improved their performance.\n  source: Figure 1C\n  quote: On the accelerating rotarod test, parkinsonian mice showed a lower latency to fall, but\n    improved with pramipexole (PPX) (0.5 mg/kg)\n  statistics:\n  - about: Ctrl against Park/PPX\n    test: Kruskal-Wallis, Dunn's\n    p: 0.001\n    p_relation: \"<\"\n  - about: Park against PPX\n    test: Kruskal-Wallis, Dunn's\n    p: 0.001\n    p_relation: \"<\"\n  - about: Park against saline\n    test: Kruskal-Wallis, Dunn's\n    p: 0.95\n    n: Ctrl 31, Park/PPX 45, Park/Saline 27 mice\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1_Rotarod_PPX.xlsx)\n- id: figs1ef-ppx-locomotion\n  statement: PPX acutely reduced movement in both control and parkinsonian mice, and increased\n    locomotion at later time points in parkinsonian mice only.\n  source: Results, Dopamine D2/3R agonist pramipexole causes impulsive decision-making in parkinsonian\n    mice, paragraph 1; Figure S1E and F\n  quote: PPX caused an acute reduction in movement in both control and parkinsonian mice. However,\n    increased locomotor activity was seen at later time points in parkinsonian mice\n  statistics:\n  - about: control, velocity at 240-300 min after PPX against before\n    test: Wilcoxon signed-rank\n    p: 0.074\n    n: 7 mice (legend), 8 (Table 1)\n  - about: parkinsonian, velocity at 240-300 min after PPX against before\n    test: Wilcoxon signed-rank\n    p: 0.02\n    n: 15 mice\n  criterion: The later effect is judged as in the Supplementary methods, average open field velocity\n    at 240-300 min after PPX against baseline, Wilcoxon signed-rank. Reproduced when this is\n    significant (p < 0.05) and higher in parkinsonian mice and not significant in controls. The\n    acute reduction has no test or window in the paper; it is reported as the mean velocity in the\n    first 30 min and the first 60 min after injection against baseline.\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (the deposit lists no PPX open field file by name; the\n    author is to find it there)\n- id: figs1-instrumental-learning\n  statement: Parkinsonian mice had slightly slower response latencies and learning in the first\n    instrumental learning phase but reached performance similar to controls in the second.\n  source: Results, Dopamine D2/3R agonist pramipexole causes impulsive decision-making in parkinsonian\n    mice, paragraph 2; Figure S1H-L\n  quote: Parkinsonian mice showed slightly slower response latencies and learning rates during the\n    first phase ... but eventually achieved similar performance in the second phase\n  statistics:\n  - about: success rate, blocked learning, sessions 1 to 6\n    test: Mann-Whitney U, Bonferroni\n    statistic: session 1 p < 0.01, 2 p = 0.06, 3 p < 0.05, 4 p < 0.01, 5 p = 0.10, 6 p = 0.09\n    p: 0.01\n    p_relation: \"<\"\n    n: 34 control and 81 parkinsonian mice\n  - about: success rate, random learning, sessions 1 to 6\n    test: Mann-Whitney U, Bonferroni\n    p: 0.56\n    n: 34 control and 81 parkinsonian mice\n  criterion: Per session, control against parkinsonian by Mann-Whitney U with Bonferroni correction\n    over six sessions (Table 1). Reproduced when at least one of sessions 1 to 4 of blocked learning\n    differs at p < 0.05 with parkinsonian mice lower, and no session of random learning differs.\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1&2&5&6_CognitiveAssay.zip)\n- id: fig1fg-baseline-similar\n  statement: PPX-naive control and parkinsonian mice showed similar delay discounting.\n  source: Results, Dopamine D2/3R agonist pramipexole causes impulsive decision-making in parkinsonian\n    mice, paragraph 2; Figure 1F and G\n  quote: PPX-naive control and parkinsonian mice showed similar delay discounting\n  statistics:\n  - about: depletion main effect\n    test: two-way ANOVA, Bonferroni\n    statistic: F(1, 180) = 3.14e-003\n    p: 0.9554\n    n: 16 control and 31 parkinsonian mice\n  criterion: A claim of absence, judged on the paper's test (Table 1), a two-way ANOVA of the\n    percentage of delayed/large choices on group and delay, with Bonferroni comparisons per delay.\n    Reproduced when the group effect and every per-delay comparison have p >= 0.05. The baseline is\n    each mouse's mean over its stable baseline sessions; how many sessions is not fixed (at least\n    three consecutive stable sessions, Supplementary methods), so the last three are used and all\n    baseline sessions shown as a variant.\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1&2&5&6_CognitiveAssay.zip)\n- id: fig1f-ctrl-ppx-no-change\n  statement: PPX did not change delay discounting in healthy control mice.\n  source: Figure 1F\n  quote: PPX did not significantly change decision-making in healthy control mice\n  statistics:\n  - about: PPX main effect\n    test: two-way repeated measures ANOVA, Bonferroni\n    statistic: F(1, 60) = 0.9564\n    p: 0.332\n    n: 16 mice\n  criterion: A claim of absence, judged on the paper's test, two-way repeated measures ANOVA of the\n    percentage of delayed/large free choices on treatment (baseline, PPX ON) and delay, with\n    Bonferroni comparisons per delay. Reproduced when the PPX effect and all four per-delay\n    comparisons have p >= 0.05. Which PPX sessions form \"PPX\" is open; readings are (a) the first\n    PPX ON session, (b) each mouse's mean over its four PPX ON sessions, as Summary_Cognitive.m\n    averages a mouse's sessions within a condition.\n  depends_on:\n  - fig1fg-baseline-similar\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1&2&5&6_CognitiveAssay.zip)\n- id: fig1g-park-ppx-fewer-large\n  statement: In parkinsonian mice PPX reduced the likelihood of choosing the delayed/large reward at\n    every delay.\n  source: Figure 1G; Results, Dopamine D2/3R agonist pramipexole causes impulsive decision-making in\n    parkinsonian mice, paragraph 2\n  quote: but reduced the likelihood of delayed/large choices at every delay in parkinsonian mice\n  statistics:\n  - about: PPX main effect\n    test: two-way repeated measures ANOVA\n    statistic: F(1, 120) = 95.48\n    p: 0.0001\n    p_relation: \"<\"\n    n: 31 mice\n  - about: 0 s\n    test: Bonferroni\n    p: 0.0001\n    p_relation: \"<\"\n  - about: 3 s\n    test: Bonferroni\n    p: 0.0001\n    p_relation: \"<\"\n  - about: 6 s (Table 1 gives p = 0.0001; the legend gives P < 0.0001)\n    test: Bonferroni\n    p: 0.0001\n  - about: 9 s (Table 1 gives p = 0.0087; the legend gives P < 0.0087)\n    test: Bonferroni\n    p: 0.0087\n  criterion: As fig1f-ctrl-ppx-no-change, on the 31 parkinsonian mice. Reproduced when, under one\n    reading of the PPX sessions, the PPX effect has p < 0.05 and the percentage of delayed/large\n    choices is lower under PPX with Bonferroni p < 0.05 at all four delays; partially reproduced\n    when the main effect holds and two or three delays are significant.\n  depends_on:\n  - fig1fg-baseline-similar\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1&2&5&6_CognitiveAssay.zip)\n- id: fig1ijk-ppx-a-k-auc\n  statement: In parkinsonian mice PPX decreased A, increased K and reduced the area under the\n    discounting curve.\n  source: Figure 1I-K; Results, Dopamine D2/3R agonist pramipexole causes impulsive decision-making in\n    parkinsonian mice, paragraph 4\n  quote: PPX had variable effects on A and K in individual parkinsonian mice, but overall led to a\n    decrease in A and increase in K ... PPX treatment led to a significant reduction in AUC in\n    parkinsonian mice\n  statistics:\n  - about: A\n    test: Friedman, Dunn's\n    p: 0.0001\n    p_relation: \"<\"\n    n: 31 mice\n  - about: K\n    test: Friedman, Dunn's\n    p: 0.03\n    n: 31 mice\n  - about: AUC\n    test: Friedman, Dunn's\n    p: 0.0001\n    p_relation: \"<\"\n    n: 31 mice\n  criterion: Per mouse and condition, the mean percentage of delayed/large choices at each delay\n    over the condition's sessions, fitted with V = A/(1 + K D) by least squares (start A = 1,\n    K = 0.5, unbounded), and AUC the trapezoidal integral of the fitted values at 0, 3, 6 and 9 s,\n    as Summary_Cognitive.m does. Friedman test over baseline, PPX ON and PPX OFF with Dunn's\n    comparison of baseline against PPX ON (Supplementary methods). Reproduced when A is lower, K\n    higher and AUC lower under PPX, each at p < 0.05. The paper writes V = 100 x A/(1 + K D), the\n    code fits the column as stored; whether the fit is on fractions or percentages changes A and\n    AUC by a constant factor only and not the test. Which PPX sessions enter is open as in\n    fig1f-ctrl-ppx-no-change; both readings are run.\n  depends_on:\n  - fig1g-park-ppx-fewer-large\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1&2&5&6_CognitiveAssay.zip)\n- id: figs2abc-sex-similar\n  statement: Male and female parkinsonian mice showed similar impulsivity after PPX.\n  source: Results, Dopamine D2/3R agonist pramipexole causes impulsive decision-making in parkinsonian\n    mice, paragraph 2; Figure S2A-C\n  quote: We found that male and female mice exhibited similar impulsivity after PPX treatment\n  statistics:\n  - about: sex main effect, PPX sessions\n    test: two-way ANOVA, Bonferroni\n    statistic: F(1, 116) = 2.87\n    p: 0.0931\n    n: 12 male and 19 female mice\n  criterion: A claim of absence, judged on the paper's test, two-way ANOVA of the percentage of\n    delayed/large choices under PPX on sex and delay with Bonferroni comparisons per delay.\n    Reproduced when the sex effect and every per-delay comparison have p >= 0.05.\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1&2&5&6_CognitiveAssay.zip)\n- id: figs2de-omissions-low\n  statement: Omission rates were low at baseline and under PPX; PPX did not change center or side\n    omissions, except center omissions at the 6 s delay in parkinsonian mice.\n  source: Results, Dopamine D2/3R agonist pramipexole causes impulsive decision-making in parkinsonian\n    mice, paragraph 3; Figure S2D and E\n  quote: Mice showed low omission rates during baseline and PPX sessions\n  statistics:\n  - about: center omissions, parkinsonian, 6 s\n    test: two-way ANOVA, Bonferroni\n    p: 0.0006\n    n: 31 mice\n  - about: side omissions, parkinsonian, PPX main effect\n    test: two-way ANOVA\n    statistic: F(1, 120) = 2.06\n    p: 0.1536\n    n: 31 mice\n  criterion: Omissions as a percentage of free choice trials, center and side apart, two-way ANOVA\n    on treatment and delay with Bonferroni comparisons per delay (Table 1). Reproduced when no\n    per-delay comparison of side omissions is significant in either group, and center omissions\n    differ only at 6 s in parkinsonian mice. \"Low\" has no threshold in the paper; the mean rates\n    are reported.\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1&2&5&6_CognitiveAssay.zip)\n- id: figs2gh-ppx-latency\n  statement: In parkinsonian mice on PPX, the latency to choose the immediate/small reward was shorter\n    than at baseline, and the modulation of choice latency by outcome was lost.\n  source: Results, Dopamine D2/3R agonist pramipexole causes impulsive decision-making in parkinsonian\n    mice, paragraph 3; Figure S2G and H\n  quote: In parkinsonian mice treated with PPX, the latency to choose small/immediate rewards was\n    shorter than at baseline, and modulation in response latencies according to outcome was absent\n  statistics:\n  - about: PPX effect on latency to small reward, parkinsonian\n    test: two-way ANOVA, Bonferroni\n    statistic: F(1, 114) = 4.505\n    p: 0.02\n    n: 31 mice\n  - about: reward size effect on latency, parkinsonian on PPX\n    test: two-way ANOVA, Bonferroni\n    statistic: F(1, 117) = 0.1514\n    p: 0.6979\n    n: 31 mice\n  - about: reward size effect on latency, parkinsonian at baseline\n    test: two-way ANOVA, Bonferroni\n    statistic: F(1, 114) = 7.016\n    p: 0.0092\n    n: 31 mice\n  criterion: Latency from side cue light to side nosepoke on free choice trials, omissions excluded\n    (Supplementary methods). Reproduced when the PPX effect on small-reward latency has p < 0.05\n    with shorter latencies on PPX, the reward size effect at baseline has p < 0.05, and the reward\n    size effect on PPX has p >= 0.05.\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1&2&5&6_CognitiveAssay.zip)\n- id: figs2ijk-ppx-washout\n  statement: After a 48 h PPX washout the A value of parkinsonian mice returned to baseline while the\n    changes in K and AUC persisted.\n  source: Results, Dopamine D2/3R agonist pramipexole causes impulsive decision-making in parkinsonian\n    mice, paragraph 4; Figure S2I-K\n  quote: in sessions following a 48 h PPX washout period, the A value recovered to baseline values,\n    while differences in K and AUC persisted\n  statistics:\n  - about: A, baseline against PPX OFF\n    test: Friedman, Dunn's (legend); one-way ANOVA, Bonferroni (Table 1)\n    p: 0.99\n    p_relation: \">\"\n    n: 31 mice\n  - about: K, baseline against PPX OFF\n    test: Friedman, Dunn's (legend); one-way ANOVA, Bonferroni (Table 1)\n    p: 0.01\n    n: 31 mice\n  - about: AUC, baseline against PPX OFF\n    test: Friedman, Dunn's (legend); one-way ANOVA, Bonferroni (Table 1)\n    p: 0.01\n    p_relation: \"<\"\n    n: 31 mice\n  criterion: A, K and AUC as in fig1ijk-ppx-a-k-auc, for baseline, PPX ON and PPX OFF (48 h after\n    each PPX injection). The test is named two ways; readings are (a) Friedman with Dunn's\n    comparisons (Supplementary methods and Figure 1 legend), (b) repeated measures one-way ANOVA\n    with Bonferroni comparisons (Table 1). Reproduced when baseline against PPX OFF has p >= 0.05\n    for A and p < 0.05 for K and AUC, in the same direction as under PPX.\n  depends_on:\n  - fig1ijk-ppx-a-k-auc\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1&2&5&6_CognitiveAssay.zip)\n- id: fig2bc-a77636-locomotion\n  statement: A77636 (1 mg/kg) increased locomotor speed in parkinsonian but not healthy mice.\n  source: Results, Dopamine D1R agonist A77636 causes impulsive decision-making in parkinsonian mice,\n    paragraph 1; Figure 2B and C\n  quote: At a dose of 1 mg/kg, A77636 increased locomotor speed in parkinsonian but not healthy mice\n  statistics:\n  - about: control, before against A77636\n    test: Wilcoxon signed-rank\n    p: 0.16\n    n: 10 mice\n  - about: parkinsonian, before against A77636\n    test: Wilcoxon signed-rank\n    p: 0.02\n    n: 16 mice\n  criterion: Open field velocity 30-100 min after A77636 against baseline, Wilcoxon signed-rank\n    (Supplementary methods). Reproduced when parkinsonian mice are faster at p < 0.05 and controls\n    show p >= 0.05. The baseline window is not given; the 20 min before injection, as for CNO, is\n    used.\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_A77636OpenField_Raw.zip)\n- id: fig2d-ctrl-a77636-no-change\n  statement: A77636 did not change delay discounting in healthy control mice.\n  source: Figure 2D\n  quote: A77636 did not significantly change decision-making in healthy control mice\n  statistics:\n  - about: A77636 main effect\n    test: two-way repeated measures ANOVA, Bonferroni\n    statistic: F(1, 36) = 1.05\n    p: 0.3115\n    n: 10 mice\n  criterion: A claim of absence, judged as fig1f-ctrl-ppx-no-change with A77636 ON sessions (30 min\n    after injection) in place of PPX ON.\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1&2&5&6_CognitiveAssay.zip)\n- id: fig2e-park-a77636-fewer-large\n  statement: A77636 shifted the discounting curve of parkinsonian mice toward immediate/small rewards,\n    with significant reductions at the 3, 6 and 9 s delays.\n  source: Figure 2E; Results, Dopamine D1R agonist A77636 causes impulsive decision-making in\n    parkinsonian mice, paragraph 1\n  quote: A77636 shifted the discounting curve in parkinsonian mice towards immediate/small rewards\n  statistics:\n  - about: A77636 main effect\n    test: two-way repeated measures ANOVA\n    statistic: F(1, 60) = 45.68\n    p: 0.0001\n    p_relation: \"<\"\n    n: 16 mice\n  - about: 0 s\n    test: Bonferroni\n    p: 0.57\n  - about: 3 s\n    test: Bonferroni\n    p: 0.0047\n  - about: 6 s\n    test: Bonferroni\n    p: 0.0003\n  - about: 9 s\n    test: Bonferroni\n    p: 0.0002\n  criterion: As fig1g-park-ppx-fewer-large with A77636 ON sessions. The legend says \"at every delay\"\n    but reports p = 0.57 at 0 s; the claim follows the numbers. Reproduced when the main effect has\n    p < 0.05 and the percentage is lower with Bonferroni p < 0.05 at 3, 6 and 9 s; partially\n    reproduced when the main effect holds and one or two of these delays are significant.\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1&2&5&6_CognitiveAssay.zip)\n- id: fig2fgh-a77636-k-auc\n  statement: In parkinsonian mice A77636 did not change A but increased K and reduced AUC.\n  source: Figure 2F-H; Results, Dopamine D1R agonist A77636 causes impulsive decision-making in\n    parkinsonian mice, paragraph 1\n  quote: A77636 had no significant effects on A in parkinsonian mice, but led to a significant increase\n    in K ... A77636 also reduced the AUC\n  statistics:\n  - about: A\n    test: Friedman, Dunn's\n    p: 0.31\n    n: 16 mice\n  - about: K\n    test: Friedman, Dunn's\n    p: 0.0053\n    n: 16 mice\n  - about: AUC (Table 1 gives p = 0.0008, the legend P < 0.0008)\n    test: Friedman, Dunn's\n    p: 0.0008\n    n: 16 mice\n  criterion: As fig1ijk-ppx-a-k-auc with A77636 sessions. Reproduced when A shows p >= 0.05, K is\n    higher at p < 0.05 and AUC lower at p < 0.05.\n  depends_on:\n  - fig2e-park-a77636-fewer-large\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1&2&5&6_CognitiveAssay.zip)\n- id: figs3-a77636-washout-latency\n  statement: The K and AUC changes under A77636 persisted after a 48 h washout; omissions stayed low\n    and A77636 abolished the outcome-dependent modulation of choice latency.\n  source: Results, Dopamine D1R agonist A77636 causes impulsive decision-making in parkinsonian mice,\n    paragraph 1; Figure S3\n  quote: Similarly to our observations with PPX, the differences in K and AUC persisted even after a\n    48 h A77636 washout period ... Like PPX, A77636 led to a loss of outcome-dependent modulation of\n    choice latency\n  statistics:\n  - about: K, A77636 against A77636 OFF\n    test: Friedman, Dunn's\n    p: 0.96\n    n: 16 mice\n  - about: AUC, A77636 against A77636 OFF\n    test: Friedman, Dunn's\n    p: 0.43\n    n: 16 mice\n  - about: reward size effect on latency, parkinsonian on A77636\n    test: two-way ANOVA\n    statistic: F (1, 55) = 3.463\n    p: 0.07\n  criterion: Reproduced when K and AUC under A77636 OFF do not differ from A77636 ON (p >= 0.05, as\n    the paper tests it) and differ from baseline in the same direction, and the reward size effect\n    on latency is significant at baseline but not on A77636.\n  depends_on:\n  - fig2fgh-a77636-k-auc\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1&2&5&6_CognitiveAssay.zip)\n- id: fig3a-a-correlates-dms\n  statement: In parkinsonian mice on PPX, A was positively correlated with residual TH fluorescence in\n    the DMS but not in the DLS or VS.\n  source: Figure 3A; Results, Changes in sensitivity to reward size relate to dopaminergic lesions in\n    the striatum\n  quote: in parkinsonian mice treated with PPX, A values were positively correlated with residual TH\n    immunofluorescence in the DMS, but not in the DLS or VS\n  statistics:\n  - about: DMS\n    test: Pearson correlation\n    statistic: r = 0.51\n    p: 0.006\n    n: 28 mice\n  - about: DLS\n    test: Pearson correlation\n    statistic: r = 0.30\n    p: 0.11\n    n: 28 mice\n  - about: VS\n    test: Pearson correlation\n    statistic: r = 0.35\n    p: 0.07\n    n: 28 mice\n  expected:\n  - quantity: Pearson r, A on PPX against DMS TH\n    value: 0.51\n    tolerance: 0.051\n  criterion: A from fig1ijk-ppx-a-k-auc, TH as in fig1b-th-loss. Reproduced when r in DMS is within\n    tolerance with p < 0.05 and DLS and VS give p >= 0.05.\n  depends_on:\n  - fig1ijk-ppx-a-k-auc\n  - fig1b-th-loss\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (CognitiveAssay and HistologyQuantification files)\n- id: fig3b-k-no-correlation\n  statement: K on PPX did not correlate with TH fluorescence in DMS, DLS or VS.\n  source: Figure 3B\n  quote: K values did not correlate with TH immunofluorescence, whether in DMS, DLS or VS\n  statistics:\n  - about: DLS\n    test: Pearson correlation\n    statistic: r = 0.34\n    p: 0.07\n    n: 28 mice\n  - about: DMS\n    test: Pearson correlation\n    statistic: r = -0.02\n    p: 0.92\n    n: 28 mice\n  - about: VS\n    test: Pearson correlation\n    statistic: r = 0.18\n    p: 0.36\n    n: 28 mice\n  criterion: A claim of absence, judged on the paper's test, Pearson correlation at p < 0.05 in each\n    subregion. Reproduced when none is significant.\n  depends_on:\n  - fig1ijk-ppx-a-k-auc\n  - fig1b-th-loss\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (CognitiveAssay and HistologyQuantification files)\n- id: figs4-a77636-no-correlation\n  statement: A77636-induced impulsivity (A and K) did not correlate with dopaminergic lesions in any\n    striatal subregion.\n  source: Figure S4; Results, Changes in sensitivity to reward size relate to dopaminergic lesions in\n    the striatum\n  quote: A77636-induced impulsivity did not correlate with dopaminergic lesions in any subregions of\n    the striatum\n  statistics:\n  - about: smallest p of the six correlations (K against VS TH)\n    test: Pearson correlation\n    statistic: r = -0.31\n    p: 0.23\n    n: 16 mice (legend); Table 1 gives N = 28\n  criterion: A claim of absence, judged by Pearson correlation of A and of K with TH in DLS, DMS and\n    VS at p < 0.05. Reproduced when none of the six is significant.\n  depends_on:\n  - fig2fgh-a77636-k-auc\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (CognitiveAssay and HistologyQuantification files)\n- id: fig4bc-baseline-rates-similar\n  statement: Under baseline conditions the firing rates of optically identified dMSNs and iMSNs were\n    comparable in control and parkinsonian mice.\n  source: Figure 4B and C; Results, Pramipexole triggers bidirectional changes in striatal activity in\n    parkinsonian mice, paragraph 1\n  quote: under baseline conditions, the dMSN and iMSN firing rates were comparable in control and\n    parkinsonian mice\n  statistics:\n  - about: dMSNs\n    test: Mann-Whitney U\n    p: 0.17\n    n: control 3 mice, 12 cells; parkinsonian 5 mice, 24 cells\n  - about: iMSNs\n    test: Mann-Whitney U\n    p: 0.7\n    n: control 4 mice, 10 cells; parkinsonian 4 mice, 16 cells\n  criterion: A claim of absence, judged on the paper's test. Per optically identified unit, the mean\n    rate over -30 to 0 min before PPX; control against parkinsonian by Mann-Whitney U per cell type\n    (Supplementary methods, In vivo electrophysiology). Reproduced when both give p >= 0.05; the\n    medians are reported. Unit selection and session follow the readings in the opening comment.\n  data: dataset\n- id: fig4de-ctrl-immediate-suppression\n  statement: In healthy mice PPX immediately suppressed the activity of both dMSNs and iMSNs.\n  source: Figure 4D and E; Results, Pramipexole triggers bidirectional changes in striatal activity in\n    parkinsonian mice, paragraph 1\n  quote: In healthy mice, PPX immediately suppressed activity in both dMSNs and iMSNs\n  criterion: The paper gives no window or test for the early effect. Using the paper's 1 min bins\n    and baseline (-30 to 0 min) and its within-unit test (Wilcoxon signed-rank on unit means, as for\n    Figure 4D-G), the post-injection window is open; readings are 0 to 30 min and 0 to 60 min.\n    Reproduced when, under one reading, the mean rate of control dMSNs and of control iMSNs is lower\n    than baseline with p < 0.05; partially reproduced when lower in both but significant in one.\n  data: dataset\n- id: fig4de-ctrl-no-change-4-5h\n  statement: In healthy mice dMSN and iMSN firing had returned to baseline by 4-5 h after PPX.\n  source: Figure 4D and E\n  quote: but firing returned to baseline levels by 4–5 h\n  statistics:\n  - about: control dMSNs, baseline against 4-5 h\n    test: Wilcoxon signed-rank\n    p: 0.91\n    n: 3 mice, 12 cells\n  - about: control iMSNs, baseline against 4-5 h\n    test: Wilcoxon signed-rank\n    p: 0.38\n    n: 4 mice, 10 cells\n  criterion: A claim of absence, judged on the paper's test. Per unit the mean rate over -30 to 0 min\n    and over 240 to 300 min after PPX, compared across units by Wilcoxon signed-rank (Supplementary\n    methods). Reproduced when both cell types give p >= 0.05; the median change is reported.\n  data: dataset\n- id: fig4f-park-dmsn-increase\n  statement: In parkinsonian mice PPX increased the firing rates of optically identified dMSNs at 4-5 h.\n  source: Figure 4F; Results, Pramipexole triggers bidirectional changes in striatal activity in\n    parkinsonian mice, paragraph 1\n  quote: PPX increased dMSN firing rates and decreased iMSN firing rates\n  statistics:\n  - test: Wilcoxon signed-rank\n    p: 0.01\n    n: 5 mice, 24 cells\n  criterion: As fig4de-ctrl-no-change-4-5h on parkinsonian dMSNs. Reproduced when the rate at\n    240-300 min is higher than baseline with p < 0.05.\n  data: dataset\n- id: fig4g-park-imsn-decrease\n  statement: In parkinsonian mice PPX decreased the firing rates of optically identified iMSNs at 4-5 h.\n  source: Figure 4G\n  quote: PPX increased dMSN firing rates and decreased iMSN firing rates\n  statistics:\n  - test: Wilcoxon signed-rank\n    p: 0.001\n    p_relation: \"<\"\n    n: 4 mice, 16 cells\n  criterion: As fig4de-ctrl-no-change-4-5h on parkinsonian iMSNs. Reproduced when the rate at\n    240-300 min is lower than baseline with p < 0.05.\n  data: dataset\n- id: fig4-insets-response-types\n  statement: In parkinsonian mice the proportion of 'increase'-type dMSNs and 'decrease'-type iMSNs\n    was larger than in controls, where most labelled MSNs showed no change.\n  source: Figure 4D-G, insets; Results, Pramipexole triggers bidirectional changes in striatal\n    activity in parkinsonian mice, paragraph 1\n  quote: In healthy mice, the majority of dMSNs and iMSNs showed no change ... the proportion of\n    ‘increase’-type dMSNs and ‘decrease’-type iMSNs was increased\n  statistics:\n  - about: dMSNs, control against parkinsonian\n    test: Fisher's exact\n    p: 0.01\n    n: control 12 cells, parkinsonian 24 cells\n  - about: iMSNs, control against parkinsonian\n    test: Fisher's exact\n    p: 0.002\n    n: control 10 cells, parkinsonian 16 cells\n  expected:\n  - quantity: control dMSNs, increase / decrease / no change (increase given)\n    value: 15.4\n    tolerance: 1.54\n    unit: percent\n  - quantity: control dMSNs, decrease\n    value: 15.4\n    tolerance: 1.54\n    unit: percent\n  - quantity: control dMSNs, no change\n    value: 69.2\n    tolerance: 6.92\n    unit: percent\n  - quantity: control iMSNs, increase\n    value: 10.0\n    tolerance: 1.0\n    unit: percent\n  - quantity: control iMSNs, decrease\n    value: 30.0\n    tolerance: 3.0\n    unit: percent\n  - quantity: control iMSNs, no change\n    value: 60.0\n    tolerance: 6.0\n    unit: percent\n  - quantity: parkinsonian dMSNs, increase\n    value: 58.3\n    tolerance: 5.83\n    unit: percent\n  - quantity: parkinsonian dMSNs, decrease\n    value: 16.7\n    tolerance: 1.67\n    unit: percent\n  - quantity: parkinsonian dMSNs, no change\n    value: 25.0\n    tolerance: 2.5\n    unit: percent\n  - quantity: parkinsonian iMSNs, increase\n    value: 0\n    tolerance: 0\n    unit: percent\n  - quantity: parkinsonian iMSNs, decrease\n    value: 72.7\n    tolerance: 7.27\n    unit: percent\n  - quantity: parkinsonian iMSNs, no change\n    value: 27.3\n    tolerance: 2.73\n    unit: percent\n  criterion: Response types as in the opening comment, on optically identified units. The printed\n    percentages fit 13 control dMSNs (2, 2, 9) and 11 parkinsonian iMSNs (0, 8, 3), while the legend\n    gives n = 12 and n = 16; the control iMSN (1, 3, 6 of 10) and parkinsonian dMSN (14, 4, 6 of 24)\n    percentages fit their n. Readings of the denominators are (a) all labelled units of Figure 4B-C\n    (12, 10, 24, 16), (b) the subset the percentages imply. Reproduced when, under one reading, the\n    percentages are within tolerance (or the counts match those implied) and Fisher's exact tests\n    (2 x 3, control against parkinsonian) give p < 0.05 for both cell types, with more 'increase'\n    dMSNs and more 'decrease' iMSNs in parkinsonian mice. Partially reproduced when the Fisher\n    tests and directions hold but the percentages do not.\n  depends_on:\n  - fig4f-park-dmsn-increase\n  - fig4g-park-imsn-decrease\n  data: dataset\n- id: fig4hk-modulation-more-marked\n  statement: The PPX modulation of dMSN and iMSN firing, normalized to baseline, was more marked in\n    parkinsonian than in healthy mice.\n  source: Figure 4H-K; Results, Pramipexole triggers bidirectional changes in striatal activity in\n    parkinsonian mice, paragraph 1\n  quote: Not only was this modulation more marked in parkinsonian mice\n  criterion: The paper reports no test and does not define the normalization. Readings of the\n    normalized response are (a) the rate at 240-300 min divided by the baseline rate (-30 to 0 min)\n    per unit, (b) the difference of the two divided by the baseline. Reproduced when, under one\n    reading, the parkinsonian median is above the control median for dMSNs and below it for iMSNs;\n    a Mann-Whitney U test (the paper's between-group test for firing rates) is reported for each\n    without being required.\n  data: dataset\n- id: figs5abcd-putative-msns\n  statement: The larger pool of unlabelled putative MSNs showed the same pattern; in parkinsonian\n    mice 54 of 214 increased, 78 decreased and 82 did not change after PPX, and the proportions of\n    response types differed from control mice.\n  source: Figure S5A-D; Results, Pramipexole triggers bidirectional changes in striatal activity in\n    parkinsonian mice, paragraph 2\n  quote: Importantly, similar patterns were seen in the larger unlabelled MSN pool\n  statistics:\n  - about: response type proportions, control against parkinsonian\n    test: Fisher's exact\n    p: 0.0003\n    n: control 7 mice, 117 cells; parkinsonian 11 mice, 214 cells\n  expected:\n  - quantity: parkinsonian putative MSNs, increase type\n    value: 54\n    tolerance: 5.4\n    unit: units\n  - quantity: parkinsonian putative MSNs, decrease type\n    value: 78\n    tolerance: 7.8\n    unit: units\n  - quantity: parkinsonian putative MSNs, no change\n    value: 82\n    tolerance: 8.2\n    unit: units\n  - quantity: control putative MSNs, increase type (Figure S5D pie chart)\n    value: 19.7\n    tolerance: 1.97\n    unit: percent\n  - quantity: control putative MSNs, decrease type (Figure S5D pie chart)\n    value: 19.7\n    tolerance: 1.97\n    unit: percent\n  - quantity: control putative MSNs, no change (Figure S5D pie chart)\n    value: 60.7\n    tolerance: 6.07\n    unit: percent\n  criterion: Putative MSNs (labelled and unlabelled) classified into response types as in the opening\n    comment, under its readings of MSN classification, pairing and session. Reproduced when, under\n    one reading, the counts and percentages are within tolerance and a 2 x 3 Fisher's exact test of\n    control against parkinsonian gives p < 0.05; partially reproduced when the test holds and the\n    parkinsonian pool has more 'decrease' than 'increase' units but the values miss tolerance.\n  data: dataset\n- id: figs5ef-saline-no-change\n  statement: After saline injection instead of PPX nearly all putative MSNs in parkinsonian mice\n    showed no change in firing rate (37 of 40).\n  source: Figure S5E and F; Results, Pramipexole triggers bidirectional changes in striatal activity\n    in parkinsonian mice, paragraph 2\n  quote: Nearly all units showed no change in firing rate\n  expected:\n  - quantity: no change units after saline\n    value: 37\n    tolerance: 3.7\n    unit: units of 40\n  - quantity: increase type after saline\n    value: 1\n    unit: units\n  - quantity: decrease type after saline\n    value: 2\n    unit: units\n  criterion: Saline sessions (4 mice, 40 putative MSNs) classified as in the opening comment.\n    Reproduced when at least 90% of units are 'no change' and the 'no change' count is within\n    tolerance. The increase and decrease counts are reported without a tolerance (one or two units).\n  data: dataset\n- id: figs6-dreadd-validation\n  statement: In slices CNO reduced optically evoked IPSCs from hM4Di-expressing iMSNs and increased\n    the firing of hM3Dq-expressing dMSNs.\n  source: Results, Chemogenetic manipulations of striatal neurons mimic the effect of pramipexole in\n    parkinsonian mice, paragraph 1; Figure S6\n  quote: Application of the DREADD agonist, clozapine-N-oxide (CNO), reduced oIPSC amplitude ...\n    Application of CNO triggered a significant increase in firing rate\n  statistics:\n  - about: oIPSC amplitude\n    test: Wilcoxon signed-rank\n    p: 0.01\n    p_relation: \"<\"\n    n: 2 mice, 6 cells\n  - about: dMSN firing to 300 pA\n    test: Wilcoxon signed-rank\n    p: 0.01\n    n: 3 mice, 9 cells\n  - about: input-output curve, CNO effect\n    test: two-way ANOVA, Bonferroni\n    statistic: F(1, 32) = 17.64\n    p: 0.0002\n    n: 3 mice, 9 cells\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_FigS6_SliceValidation.xlsx)\n- id: fig5cf-cno-locomotion\n  statement: In parkinsonian mice CNO increased locomotion in hM4Di and hM3Dq mice but not in mCherry\n    controls.\n  source: Figure 5C-F; Results, Chemogenetic manipulations of striatal neurons mimic the effect of\n    pramipexole in parkinsonian mice, paragraph 2\n  quote: injection of CNO increased locomotion in both hM4D i and hM3D q animals, but not in mCherry\n    control animals\n  criterion: As the Supplementary methods state, mean velocity -20 to 0 min before CNO against 20-30\n    min after, Wilcoxon signed-rank, per group. The paper prints no p-values; reproduced when the\n    hM4Di and hM3Dq groups are faster after CNO at p < 0.05 and the mCherry groups show p >= 0.05.\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig5_DREADDLocomotion_Raw.zip)\n- id: fig5g-mcherry-no-change\n  statement: CNO did not change delay discounting in parkinsonian mCherry control mice.\n  source: Figure 5G\n  quote: robustly shifted choices towards immediate/small rewards over delayed/large rewards in hM4D i\n    -expressing or hM3D q -expressing but not mCherry control mice\n  statistics:\n  - about: CNO main effect\n    test: two-way repeated measures ANOVA, Bonferroni\n    statistic: F(1, 56) = 0.97\n    p: 0.3297\n    n: 15 mice\n  criterion: A claim of absence, judged on the paper's test. Pre-CNO baseline against post-CNO\n    sessions averaged per mouse over four CNO sessions (Supplementary methods, Chemogenetic\n    manipulation), two-way repeated measures ANOVA with Bonferroni per delay. Reproduced when the\n    CNO effect and every per-delay test have p >= 0.05.\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1&2&5&6_CognitiveAssay.zip)\n- id: fig5hi-dreadd-fewer-large\n  statement: Chemogenetic inhibition of iMSNs (hM4Di) or excitation of dMSNs (hM3Dq) in the DMS shifted\n    choices of parkinsonian mice toward immediate/small rewards.\n  source: Figure 5H and I\n  quote: Chemogenetic inhibition of iMSNs or excitation of dMSNs robustly shifted choices towards\n    immediate/small rewards over delayed/large rewards\n  statistics:\n  - about: hM4Di, CNO main effect\n    test: two-way repeated measures ANOVA\n    statistic: F(1, 44) = 22.22\n    p: 0.0001\n    p_relation: \"<\"\n    n: 12 mice\n  - about: hM4Di per delay, 0 / 3 / 6 / 9 s (3 s given as p < 0.01)\n    test: Bonferroni\n    statistic: 0 s p > 0.99, 3 s p < 0.01, 6 s p = 0.049, 9 s p = 0.027\n    p: 0.049\n  - about: hM3Dq, CNO main effect\n    test: two-way repeated measures ANOVA\n    statistic: F(1, 44) = 42.30\n    p: 0.0001\n    p_relation: \"<\"\n    n: 12 mice\n  - about: hM3Dq per delay\n    test: Bonferroni\n    statistic: 0 s p = 0.29, 3 s p = 0.0002, 6 s p = 0.0008, 9 s p = 0.04\n    p: 0.0002\n  criterion: As fig5g-mcherry-no-change, per group. Reproduced when in each group the CNO effect has\n    p < 0.05 and choices are lower after CNO with Bonferroni p < 0.05 at 3, 6 and 9 s; partially\n    reproduced when this holds in one group, or the main effects hold with fewer delays.\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1&2&5&6_CognitiveAssay.zip)\n- id: fig5jl-dreadd-params\n  statement: CNO increased K and decreased AUC in hM4Di and hM3Dq mice; it reduced A in hM3Dq but not\n    hM4Di mice, and changed none of the three in mCherry mice.\n  source: Figure 5J-L; Results, Chemogenetic manipulations of striatal neurons mimic the effect of\n    pramipexole in parkinsonian mice, paragraph 2\n  quote: chemogenetic inhibition of indirect pathway or excitation of direct pathway significantly\n    increased the K value and decreased AUC ... CNO did not impact the A value in the hM4D i\n    -expressing group, but significantly reduced the A value in the hM3D q -expressing group\n  statistics:\n  - about: mCherry A / K / AUC\n    test: Wilcoxon signed-rank (Table 1)\n    statistic: A p = 0.89, K p = 0.45, AUC p = 0.56\n    p: 0.45\n    n: 15 mice\n  - about: hM4Di A\n    test: Wilcoxon signed-rank (Table 1)\n    p: 0.11\n    n: 12 mice\n  - about: hM4Di K\n    test: Wilcoxon signed-rank (Table 1)\n    p: 0.02\n    n: 12 mice\n  - about: hM4Di AUC\n    test: Wilcoxon signed-rank (Table 1)\n    p: 0.001\n    p_relation: \"<\"\n    n: 12 mice\n  - about: hM3Dq A\n    test: Wilcoxon signed-rank (Table 1)\n    p: 0.01\n    n: 12 mice\n  - about: hM3Dq K\n    test: Wilcoxon signed-rank (Table 1)\n    p: 0.01\n    p_relation: \"<\"\n    n: 12 mice\n  - about: hM3Dq AUC\n    test: Wilcoxon signed-rank (Table 1)\n    p: 0.001\n    p_relation: \"<\"\n    n: 12 mice\n  criterion: A, K and AUC fitted as in fig1ijk-ppx-a-k-auc on pre-CNO and post-CNO curves. The test\n    is named two ways; readings are (a) Wilcoxon signed-rank, pre against post (Table 1), (b)\n    Friedman with Dunn's comparisons (Supplementary methods). Reproduced when, under one reading, K\n    is higher and AUC lower at p < 0.05 in both DREADD groups, A is lower at p < 0.05 in hM3Dq and\n    p >= 0.05 in hM4Di, and no measure differs in mCherry mice; partially reproduced when the K and\n    AUC results hold but the A pattern does not.\n  depends_on:\n  - fig5hi-dreadd-fewer-large\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1&2&5&6_CognitiveAssay.zip)\n- id: fig6b-ctrl-ppx-stable\n  statement: In healthy control mice delay discounting stayed the same across four PPX sessions.\n  source: Figure 6B; Results, Impulsivity develops with repeated pramipexole dosing, paragraph 1\n  quote: In healthy control mice, delay discounting remained consistent across sessions\n  statistics:\n  - about: first against fourth PPX session\n    test: two-way repeated measures ANOVA, Bonferroni\n    p: 0.99\n    p_relation: \">\"\n    n: 16 mice\n  criterion: A claim of absence, judged on the paper's test, two-way repeated measures ANOVA of the\n    percentage of delayed/large choices over baseline and PPX sessions and delay, with Bonferroni\n    comparison of the first and fourth session. Reproduced when baseline against first, baseline\n    against fourth and first against fourth all have p >= 0.05.\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1&2&5&6_CognitiveAssay.zip)\n- id: fig6c-park-ppx-progressive\n  statement: In parkinsonian mice PPX-induced impulsivity grew over repeated dosing, more marked by the\n    fourth session than the first.\n  source: Figure 6C; Results, Impulsivity develops with repeated pramipexole dosing, paragraph 1\n  quote: PPX injection induced a modest increase in impulsivity, which became more marked by the\n    fourth session\n  statistics:\n  - about: first against fourth session\n    test: two-way repeated measures ANOVA, Bonferroni\n    p: 0.0081\n    p_relation: \"<\"\n    n: 31 mice\n  - about: baseline against first and against fourth\n    test: two-way repeated measures ANOVA, Bonferroni\n    p: 0.0001\n    p_relation: \"<\"\n    n: 31 mice\n  criterion: As fig6b-ctrl-ppx-stable on parkinsonian mice. Reproduced when the fourth session has\n    fewer delayed/large choices than the first with p < 0.05, and both differ from baseline at\n    p < 0.05.\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1&2&5&6_CognitiveAssay.zip)\n- id: fig6de-a77636-persistent\n  statement: A77636 increased impulsivity in parkinsonian mice from the first exposure, and the effect\n    persisted unchanged across four sessions; controls were unaffected.\n  source: Figure 6D and E; Results, Impulsivity develops with repeated pramipexole dosing, paragraph 1\n  quote: the initial exposure to A77636 treatment resulted in increased impulsivity, which persisted\n    across four consecutive treatments\n  statistics:\n  - about: parkinsonian, first against fourth\n    test: two-way repeated measures ANOVA, Bonferroni\n    p: 0.59\n    n: 16 mice\n  - about: parkinsonian, baseline against first and against fourth\n    test: two-way repeated measures ANOVA, Bonferroni\n    p: 0.0001\n    p_relation: \"<\"\n    n: 16 mice\n  - about: control, first against fourth\n    test: two-way repeated measures ANOVA, Bonferroni\n    p: 0.49\n    n: 10 mice\n  criterion: As fig6b-ctrl-ppx-stable. Reproduced when in parkinsonian mice baseline differs from the\n    first and the fourth A77636 session at p < 0.05 and first against fourth gives p >= 0.05, and in\n    controls no comparison is significant.\n  data: elsewhere\n  where: Zenodo doi:10.5281/zenodo.15258978 (Data_ICD_Fig1&2&5&6_CognitiveAssay.zip)\n- id: fig6f-ctrl-types-stable\n  statement: In control mice the proportions of MSN response types to PPX did not differ between the\n    first and fourth PPX session.\n  source: Figure 6F and Figure S8A; Results, Impulsivity develops with repeated pramipexole dosing,\n    paragraph 2\n  quote: In control mice, the proportion of response types was consistent across injection days\n  statistics:\n  - test: Fisher's exact\n    p: 0.11\n    n: first session 7 mice, 80 cells; fourth session 3 mice, 27 cells\n  expected:\n  - quantity: control, first session, increase / decrease / no change (increase given)\n    value: 11.2\n    tolerance: 1.12\n    unit: percent\n  - quantity: control, first session, decrease\n    value: 26.2\n    tolerance: 2.62\n    unit: percent\n  - quantity: control, first session, no change\n    value: 62.5\n    tolerance: 6.25\n    unit: percent\n  - quantity: control, fourth session, increase\n    value: 11.1\n    tolerance: 1.11\n    unit: percent\n  - quantity: control, fourth session, decrease\n    value: 3.7\n    tolerance: 0.37\n    unit: percent\n  - quantity: control, fourth session, no change\n    value: 85.2\n    tolerance: 8.52\n    unit: percent\n  criterion: A claim of absence, judged on the paper's test, a 2 x 3 Fisher's exact test of response\n    type counts, first against fourth PPX session, among putative MSNs classified as in the opening\n    comment. Reproduced when p >= 0.05. The percentages (read from the Figure S8A pie charts, which\n    fit the 80 and 27 units) and unit counts are reported against expected.\n  data: dataset\n- id: fig6g-park-types-shift\n  statement: In parkinsonian mice the MSN response types shifted from the first to the fourth PPX\n    session, with more 'increase'-type and fewer 'decrease'-type units.\n  source: Figure 6G and Figure S8B; Results, Impulsivity develops with repeated pramipexole dosing,\n    paragraph 2\n  quote: However, in parkinsonian mice, the response types shifted over four sessions ... Chronic PPX\n    treatment leads to a higher proportion of excited MSNs ... the proportion of ‘decrease’-type\n    MSNs falls over PPX treatment\n  statistics:\n  - test: Fisher's exact\n    p: 0.002\n    n: first session 10 mice, 105 cells; fourth session 8 mice, 75 cells\n  expected:\n  - quantity: parkinsonian, first session, increase type\n    value: 19\n    tolerance: 1.9\n    unit: units\n  - quantity: parkinsonian, first session, decrease type\n    value: 34\n    tolerance: 3.4\n    unit: units\n  - quantity: parkinsonian, fourth session, increase type\n    value: 32\n    tolerance: 3.2\n    unit: units\n  - quantity: parkinsonian, fourth session, decrease type\n    value: 15\n    tolerance: 1.5\n    unit: units\n  - quantity: parkinsonian, first session, no change (Figure S8B)\n    value: 49.5\n    tolerance: 4.95\n    unit: percent\n  - quantity: parkinsonian, fourth session, no change (Figure S8B)\n    value: 37.3\n    tolerance: 3.73\n    unit: percent\n  criterion: Putative MSNs of parkinsonian mice in the first and fourth PPX session, classified as in\n    the opening comment. Counts per type are from the Figure S8 legend (C and E, D and F); the pie\n    charts give 18.1, 32.4, 49.5% (first) and 42.7, 20.0, 37.3% (fourth). Reproduced when a 2 x 3\n    Fisher's exact test gives p < 0.05, the 'increase' share is higher and the 'decrease' share\n    lower in the fourth session, and the counts are within tolerance; partially reproduced when\n    the test and directions hold and the counts do not.\n  data: dataset\n- id: figs8-session-trend\n  statement: Across the four PPX sessions in parkinsonian mice, the number of 'increase'-type MSNs\n    rose (19, 21, 41, 32) and the number of 'decrease'-type MSNs fell (34, 45, 22, 15).\n  source: Figure S8C-F legend\n  inferred: Counts from the Figure S8 legend for sessions 1 to 4; the Results state only the\n    direction of the change (Figure 6J and K, Figure S8E and F).\n  expected:\n  - quantity: increase type, sessions 1 to 4 (session 1)\n    value: 19\n    tolerance: 1.9\n    unit: units\n  - quantity: increase type, session 2\n    value: 21\n    tolerance: 2.1\n    unit: units\n  - quantity: increase type, session 3\n    value: 41\n    tolerance: 4.1\n    unit: units\n  - quantity: increase type, session 4\n    value: 32\n    tolerance: 3.2\n    unit: units\n  - quantity: decrease type, session 1\n    value: 34\n    tolerance: 3.4\n    unit: units\n  - quantity: decrease type, session 2\n    value: 45\n    tolerance: 4.5\n    unit: units\n  - quantity: decrease type, session 3\n    value: 22\n    tolerance: 2.2\n    unit: units\n  - quantity: decrease type, session 4\n    value: 15\n    tolerance: 1.5\n    unit: units\n  criterion: Counts per session as in fig6g-park-types-shift. Reproduced when at least six of the\n    eight counts are within tolerance and the share of 'increase' units in sessions 3 and 4 exceeds\n    that in sessions 1 and 2 while the 'decrease' share falls.\n  depends_on:\n  - fig6g-park-types-shift\n  data: dataset\n- id: fig6h-increase-type-larger\n  statement: In parkinsonian mice 'increase'-type MSNs increased their firing more in response to the\n    fourth PPX injection than to the first.\n  source: Figure 6H and Figure S8C; Results, Impulsivity develops with repeated pramipexole dosing,\n    paragraph 2\n  quote: ‘increase’-type MSNs showed more dramatic increases in firing rate in response to the fourth\n    (versus first) PPX injection\n  statistics:\n  - test: Mann-Whitney U\n    p: 0.02\n    n: first session 6 mice, 19 cells; fourth session 7 mice, 32 cells\n  criterion: The 'increase'-type units of fig6g-park-types-shift, first against fourth session, by\n    Mann-Whitney U. What is compared is not fixed (\"average firing rates before and after PPX\");\n    readings are (a) the rate at 240-300 min, (b) the change from baseline, (c) the ratio to\n    baseline. Reproduced when, under one reading, the fourth session is higher at p < 0.05.\n  depends_on:\n  - fig6g-park-types-shift\n  data: dataset\n- id: fig6i-decrease-type-similar\n  statement: In parkinsonian mice 'decrease'-type MSNs responded similarly to the first and fourth PPX\n    injection.\n  source: Figure 6I and Figure S8D\n  quote: while ‘decrease’-type MSNs responded similarly across sessions\n  statistics:\n  - test: Mann-Whitney U\n    p: 0.89\n    n: first session 9 mice, 34 cells; fourth session 5 mice, 15 cells\n  criterion: A claim of absence, judged on the paper's test, Mann-Whitney U, first against fourth\n    session, on the 'decrease'-type units. The measure is open as in fig6h-increase-type-larger;\n    each reading is a separate application of the paper's test, and the claim is reproduced when\n    reading (b), the change from baseline, gives p >= 0.05, with (a) and (c) shown.\n  depends_on:\n  - fig6g-park-types-shift\n  data: dataset\n"
}
```

```
File created successfully at: claims/001177/10.1093-brain-awaf312.yaml (file state is current in your context — no need to Read it back)
```

**Agent calls Bash**

```bash
python3 - <<'EOF'
import re
p='claims/001177/10.1093-brain-awaf312.yaml'
s=open(p).read()
s=s.replace("control dMSNs, increase / decrease / no change (increase given)","control dMSNs, increase")
s=s.replace("control, first session, increase / decrease / no change (increase given)","control, first session, increase")
s=s.replace("increase type, sessions 1 to 4 (session 1)","increase type, session 1")
old="""    session, on the 'decrease'-type units. The measure is open as in fig6h-increase-type-larger;
    each reading is a separate application of the paper's test, and the claim is reproduced when
    reading (b), the change from baseline, gives p >= 0.05, with (a) and (c) shown."""
new="""    session, on the 'decrease'-type units. The measure is open as in fig6h-increase-type-larger.
    Reproduced when every reading gives p >= 0.05 and not reproduced when every reading gives
    p < 0.05; when they differ, the outcome rests on the reading adopted, with all shown."""
assert old in s; s=s.replace(old,new)
open(p,'w').write(s)
EOF
python tools/claims_check.py claims/001177/10.1093-brain-awaf312.yaml paper/10.1093-brain-awaf312.txt
```

Result: not kept, because it reads the paper's text.

**Agent calls Bash**

```bash
sed -i 's/^    n: 44$/    n: 44 sections or mice (the legend gives n = 44 without unit)/' claims/001177/10.1093-brain-awaf312.yaml && python tools/claims_check.py claims/001177/10.1093-brain-awaf312.yaml paper/10.1093-brain-awaf312.txt; grep -n "^  [a-z_]*: .*: " claims/001177/10.1093-brain-awaf312.yaml | head
```

Result: not kept, because it reads the paper's text.

**Agent calls Bash**

```bash
python3 - <<'EOF'
import yaml
d=yaml.safe_load(open('claims/001177/10.1093-brain-awaf312.yaml'))
def walk(x,path=''):
    if isinstance(x,dict):
        for k,v in x.items(): walk(v,path+'/'+str(k))
    elif isinstance(x,list):
        for i,v in enumerate(x): walk(v,path+f'/{i}')
    elif isinstance(x,str) and (': ' in x or '—' in x or 'rather' in x): print(path,x[:80])
walk(d)
c=d['claims']; print(len(c), sum('quote' in x for x in c), sum('statistics' in x for x in c), sum('criterion' in x for x in c), sum('expected' in x for x in c))
EOF
```

```
43 42 38 40 8
```

**Agent**

I wrote `claims/001177/10.1093-brain-awaf312.yaml`, and the quote checker passes it: 43 claims, 42 quotes, 85 statistical values, 0 problems. Nothing is committed.

**Text read.** I read the version of record from Europe PMC (PMC12597312), full text including Methods. I also read its one supplement, `awaf312_supplementary_data.pdf`, which holds Figures S1 to S8, the Supplementary Methods and the statistics table (Table 1). I opened two supplement PDF pages, Figures S5 and S8, only to read pie-chart percentages that the text does not hold. The main paper's figures were not available as images, so main-figure values come from the legends.

**Code read.** The paper links two behaviour repositories:
- `UCSF-Nelson-Lab/ICD-Cognitive-Analysis`, tag ICD, commit 5528e22. `Summary_Cognitive.m` settles how A, K and AUC are computed: a per-mouse mean over sessions, a least-squares fit starting at A = 1, K = 0.5, and AUC by trapezoids at 0, 3, 6 and 9 s.
- `UCSF-Nelson-Lab/ICD-Cognitive-Arduino`, commit f7cff8b, which runs the operant boxes.

No code is linked for the electrophysiology; the paper says it was analysed in NeuroExplorer and Prism.

**Claims.**
- 43 claims: 42 have a quote and 1 is `inferred` (the per-session counts in the Figure S8 legend).
- 38 have statistics, 40 have a criterion and 8 have expected values.
- 14 claims use the dandiset: the electrophysiology in Figure 4, Figure S5, Figure 6F–I and Figure S8.
- 29 are `data: elsewhere`. The paper deposited the behaviour, histology, rotarod, locomotion and slice data on Zenodo (doi:10.5281/zenodo.15258978), not on DANDI.

**Details the paper leaves open, with the readings named:**
- **Putative MSN classification:** no thresholds are given. Readings are (a) a label the authors deposited with the units, or (b) the criteria of the two papers it cites (Berke 2004, Gage 2010).
- **Optical tagging:** the bin width, the baseline window for the 99% interval and the waveform test are not given. Readings are (a) a deposited label, or (b) 1 ms bins, the pre-pulse baseline and waveform correlation.
- **Response-type test:** the paper names a signed-rank test but not how the 1 min bins are paired. Readings are (a) the 30 baseline bins paired in time order with each 30 min post epoch, or (b) an unpaired rank-sum test on the same bins. A unit significant in only one epoch is counted as "no change" and reported.
- **Session for Figure 4 and Figure S5:** (a) each mouse's first PPX session, or (b) all PPX sessions pooled.
- **Figure 4 inset denominators:** the printed percentages fit 13 control dMSNs and 11 parkinsonian iMSNs, but the legend says n = 12 and n = 16. Both denominators are named as readings.
- **Figure 4H–K "normalized response":** (a) ratio to baseline, or (b) change over baseline. The paper reports no test for these panels.
- **"Immediate" suppression in healthy mice (Figure 4D–E):** no window or test is given. Readings are 0–30 min and 0–60 min, using the paper's within-unit test.
- **Figure 6H–I measure:** (a) the post-drug rate, (b) the change from baseline, or (c) the ratio to baseline.
- **Which PPX sessions form "PPX" in Figure 1:** (a) the first session, or (b) the mean of the four, as the code averages.
- **Test name conflicts:** for Figures S2I–K and 5J–L the legends and Methods name a Friedman/Dunn's test, while Table 1 names a one-way ANOVA or Wilcoxon signed-rank. Both are named as readings.
- **Baseline window for A77636 locomotion:** not given; the 20 min before injection, the window the paper uses for CNO, is used.

**Inconsistencies recorded in the claims:**
- Figure 1G p-values: legend "<0.0001" and "<0.0087" against Table 1 "0.0001" and "0.0087".
- Figure 2E: the text says "at every delay" but reports p = 0.57 at 0 s; the claim follows the numbers.
- Figure S1E: N = 7 in the legend against 8 in Table 1.
- Figure S4: N = 16 in the legend against 28 in Table 1.

**Missing from the paper that a claim needed:**
- No p-values are printed for the CNO locomotion in Figure 5C–F.
- No PPX open-field file is named in the Zenodo deposit.
- No numeric A, K or AUC values are reported anywhere, so those claims rest on tests and directions only.

## End of run

41 turns, 7 minutes, result: success.
